Literature DB >> 2204550

Limb loss with patent infra-inguinal bypasses.

A M Dietzek1, S K Gupta, H B Kram, K R Wengerter, F J Veith.   

Abstract

To determine systemic and local risk factors that contribute to limb loss despite a patent infra-inguinal bypass graft and how to prevent it, we reviewed 987 patients who underwent infra-inguinal bypasses at our institution. Seventy-five (7.6%) patent grafts failed to achieve a healed foot despite exhaustive attempts to do so and these patients underwent major amputation either above the knee (AKA) or below the knee (BKA). In 525 femoro-popliteal bypasses, there were 38 major amputations (29 BKA; 9 AKA) with a patent graft; in 462 femoro-distal bypasses, there were 37 amputations (22 BKA; 15 AKA) with a patent graft. The remaining 912 patients with limb salvage as well as all the patients with limb loss were evaluated with regard to systemic risk factors, quality of the run-off from the popliteal artery, continuity of the tibial artery into the arch as demonstrated on arteriography, the haemodynamic improvement obtained postoperatively, and the presence and extent of necrosis in the foot. The presence of diabetes, extensive pedal necrosis and advanced infection predispose to limb loss despite a patent lower extremity bypass graft. Patients who lost their limbs despite a functioning bypass to an isolated popliteal segment had significantly less pronounced haemodynamic improvement postoperatively. An early graft extension to a reconstituted tibial or peroneal artery or a direct bypass to a distal tibial or peroneal artery may reduce the incidence of limb loss in this setting. When a patent bypass to an isolated tibial or peroneal artery segment failed to relieve foot ischaemia, limb salvage was achieved by a distal extension to plantar arteries.

Entities:  

Mesh:

Year:  1990        PMID: 2204550     DOI: 10.1016/s0950-821x(05)80877-1

Source DB:  PubMed          Journal:  Eur J Vasc Surg        ISSN: 0950-821X


  5 in total

1.  Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia.

Authors:  Jessica P Simons; Philip P Goodney; Brian W Nolan; Jack L Cronenwett; Louis M Messina; Andres Schanzer
Journal:  J Vasc Surg       Date:  2010-04-24       Impact factor: 4.268

2.  Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease.

Authors:  Neal R Barshes; Panos Kougias; C Keith Ozaki; Philip P Goodney; Michael Belkin
Journal:  J Vasc Surg       Date:  2014-03-20       Impact factor: 4.268

3.  Influence of diabetes on persistent nonhealing ischemic foot ulcer in end-stage renal disease.

Authors:  Hiroshi Yasuhara; Shuji Naka; Hironobu Yanagie; Hirokazu Nagawa
Journal:  World J Surg       Date:  2002-07-22       Impact factor: 3.352

4.  Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial.

Authors:  Liang Xiao; De-sheng Huang; Jia-jie Tong; Jing Shen
Journal:  Cardiovasc Diabetol       Date:  2012-02-28       Impact factor: 9.951

5.  Rare metastatic pancreatic tumors from lung cancer with cystic changes resembling intraductal papillary mucinous neoplasm: a case report.

Authors:  Akira Watanabe; Norifumi Harimoto; Takahiro Yamanaka; Norihiro Ishii; Mariko Tsukagoshi; Takamichi Igarashi; Norio Kubo; Kenichiro Araki; Aya Suzuki; Kenichiro Hara; Ken Shirabe
Journal:  Surg Case Rep       Date:  2020-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.